Filing Flows

Filing Flows › Maximus (MMS) › Q3 FY26 › vs Q2 FY26

Maximus (MMS) Q3 FY26 vs Q2 FY26 (quarter over quarter)

Maximus's revenue fell $27.0M (-2%) from $1.3B in Q2 FY26 to $1.3B in Q3 FY26. The biggest changes: Program Operations −$42.1M (-7%); Clinical Services +$22.3M (+4%); Employment & Other −$4.2M (-7%). Gross margin 27.3% against 26.2% (+1.1 pts).

Maximus, Q3 FY26: revenue $1.3B (-5% year over year), operating margin 12.6%, net earnings $104M, operating cash flow −$125M. The chart draws each line against Q2 FY26, the increases inside each band.

Maximus: what changed, Q3 FY26 vs Q2 FY26Maximus: what changed, Q3 FY26 vs Q2 FY26Operating cash sources$317MWorking capital & other$317MCash used in operations$315MProgram Operations−$42.1MCost of revenue−$33.5MClinical Services$22.3MOperating profit$12.9MPre-tax earnings$11.6MGross profit$6.5MOperating expenses−$6.4M

Margins

Q3 FY26Q2 FY26Change
Gross margin27.3%26.2%+1.1 pts
Operating margin12.6%11.4%+1.3 pts
Net margin8.1%7.5%+0.6 pts

Every line

LineQ3 FY26Q2 FY26Change%
Program Operations$603M$645M−$42.1M-7%
Clinical Services$553M$531M$22.3M+4%
Technology Solutions$67.2M$70.3M−$3.0M-4%
Employment & Other$55.9M$60.0M−$4.2M-7%
Revenue$1.3B$1.3B−$27.0M-2%
Gross profit$349M$342M$6.5M+2%
Cost of revenue$930M$964M−$33.5M-3%
Operating profit$161M$148M$12.9M+9%
Operating expenses$187M$194M−$6.4M-3%
Pre-tax earnings$138M$127M$11.6M+9%
Other expense, net$23.3M$22.0M$1.3M+6%
SG&A$167M$173M−$6.3M-4%
Other operating costs$20.2M$20.3M−$111K-0.5%
Net earnings$104M$98.1M$5.5M+6%
Income tax$34.6M$28.5M$6.1M+21%
Operating cash sources$248M−$69.2M$317M—
Depreciation & amortization$11.9M$12.3M−$454K-4%
Share-based compensation$7.4M$9.9M−$2.5M-26%
Cash used in operations$125M−$190M$315M—
Working capital & other$248M−$69.2M$317M—

Questions

How much did Maximus's revenue grow quarter over quarter in Q3 FY26?

Maximus's revenue fell $27.0M (-2%) from $1.3B in Q2 FY26 to $1.3B in Q3 FY26.

What drove Maximus's revenue change in Q3 FY26?

Program Operations −$42.1M (-7%); Clinical Services +$22.3M (+4%); Employment & Other −$4.2M (-7%).

Q3 FY26 results → · Compare in the interactive Sankey →